Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
FRONT PAGE STOCKS
(Total Views: 109)
Posted On: 04/21/2022 1:13:28 PM
Post# of 44400
Avatar
Posted By: Tsongbird
$BIEL THREE RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIALS

Quote:
A randomized, controlled, double-blinded study that investigated the effectiveness of RecoveryRx in treating postoperative pain in 18 women who underwent breast augmentation surgery. These women presented with the following average baseline demographics: 31.6 years of age, weight of 134 lbs and height of 5.52 ft. The primary outcome was a difference in daily pain, measured on a 0-10 visual analog pain scale. The results indicate that the effect of active treatment with RecoveryRx provides a statistically significant treatment effect (reduction in postoperative pain), when compared to placebo (p<0.05). Link to publication: (https://lnkd.in/g5kKVaPs)



https://www.linkedin.com/feed/update/urn:li:a...946411009/
886323707_wsdsorecoveryrx.jpg

(0)
(0)






Live Laugh Love

Favorite Stocks
$BIEL Bioelectronics https://www.bielcorp.com/



  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site